Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2CNS 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Thyroid Neoplasms 5Breast Neoplasms 3Thyroid Carcinoma, Anaplastic 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Head and Neck Neoplasms 2Thyroid Cancer, Papillary 1Salivary Gland Neoplasms 1Recurrent Lymphoepithelioma of the Nasopharynx 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

Surveys and Questionnaires 4Nivolumab 3pembrolizumab 2cemiplimab 2atezolizumab 2amminedichloro(2-methylpyridine)platinum(II) 2Blood Specimen Collection 2trastuzumab deruxtecan 1trametinib 1repotrectinib 1pralsetinib 1pazopanib 1motexafin gadolinium 1durvalumab 1dabrafenib 1avelumab 1alectinib 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Reverse Transcriptase Polymerase Chain Reaction 1Radiosurgery 1Quality of Life 1Patient-Specific Modeling 1Oncolytic Virotherapy 1Ocoxin 1Observation 1Mass Screening 1MLN 8237 1Immune Checkpoint Inhibitors 1Hyperspectral Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × pazopanib × Head & Neck × Clear all
NCT01639911 2019-07-22

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

University of Illinois at Chicago

Phase 1 Completed
28 enrolled
BreastCNSDermatologicGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Melanoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡